89bio Inc.

NASDAQ: ETNB · Real-Time Price · USD
9.22
0.12 (1.32%)
At close: Aug 15, 2025, 3:59 PM
9.23
0.05%
After-hours: Aug 15, 2025, 04:10 PM EDT

89bio Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 21K n/a n/a n/a 234K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
8K 10K 21K 8K 12K 9K 16K 10K 52K 55K 55K 60K 107K 18K 21K 23K 20K 15K
Gross Profit
-8K -10K n/a -8K -12K -9K -16K -10K -52K -55K -55K -60K -107K -18K -21K -23K -20K -15K
Operating Income
-115.82M -75.91M -122M -151.94M -53.44M -57.28M -41.21M -39.34M -42.13M 28.52M 25.36M -27.04M -24.74M -25.11M -26.24M -28.21M -20.55M -14.74M
Interest Income
n/a 6.04M 5.1M 5.43M 6.47M 6.56M 5.7M 5.58M 4.63M 1.76M n/a 773K 118K n/a n/a n/a n/a n/a
Pretax Income
-110.75M -71.14M -118.1M -148.87M -47.84M -51.58M -36.37M -34.73M -38.39M -28.84M -24.59M -26.8M -25.05M -25.56M -26.43M -28.33M -20.72M -14.78M
Net Income
-111.5M -71.28M -118.35M -149.07M -47.97M -51.68M -40.23M -34.73M -38.39M -84.12M -24.6M -26.8M -25.37M -25.57M -26.29M -28.33M -20.72M -14.78M
Selling & General & Admin
11.92M 11.52M 10.7M 10.5M 8.56M 9.84M 7.6M 7.93M 7.21M 6.22M 6.3M 4.84M 5.05M 5.26M 5.26M 4.62M 4.92M 4.61M
Research & Development
103.9M 64.39M 111.3M 141.44M 44.87M 47.43M 33.59M 31.42M 34.91M 22.31M 19.06M 22.2M 19.69M 19.85M 20.98M 23.59M 15.63M 10.13M
Other Expenses
n/a n/a -9K n/a n/a n/a n/a n/a n/a n/a n/a 238K n/a n/a -194K -117K -172K -43K
Operating Expenses
115.82M 75.91M 122M 151.94M 53.42M 57.27M 41.19M 39.34M 42.13M 28.52M 25.36M 27.04M 24.74M 25.11M 26.24M 28.21M 20.55M 14.74M
Interest Expense
1.14M -1.27M 1.19M 2.36M 874K 863K 866K 959K 894K 2.08M n/a 535K 434K 456K n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a -12K -9K -16K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
115.82M 75.91M 122.05M 151.94M 53.44M 57.28M 41.21M 39.34M 42.13M 28.52M 25.36M 27.04M 24.74M 25.11M 26.24M 28.21M 20.55M 14.74M
Income Tax Expense
753K -137K 257K 204K 134K 97K 3.87M -10K n/a 55.28M 16K 2K 316K 1K -147K -23K n/a -15K
Shares Outstanding (Basic)
157.88M 115.96M 115.96M 107.08M 99.83M 95.85M 80.7M 76.34M 74.13M 53.17M 50.81M 47.25M 20.35M 20.34M 20.26M 20.09M 20.06M 20.01M
Shares Outstanding (Diluted)
157.88M 115.96M 115.96M 107.08M 99.83M 95.85M 80.7M 76.34M 74.13M 53.17M 50.81M 47.25M 20.35M 20.34M 20.26M 20.09M 20.06M 20.01M
EPS (Basic)
-0.71 -0.49 -1.02 -1.39 -0.48 -0.54 -0.5 -0.45 -0.52 -1.58 -0.48 -0.57 -1.25 -1.26 -1.3 -1.41 -1.03 -0.74
EPS (Diluted)
-0.71 -0.49 -1.02 -1.39 -0.48 -0.54 -0.5 -0.45 -0.52 -1.58 -0.48 -0.57 -1.25 -1.26 -1.3 -1.41 -1.03 -0.74
EBITDA
-115.82M -75.91M -116.9M -146.5M -46.95M -50.71M -35.49M -33.76M -37.45M -26.71M -24.53M -26.74M -24.74M -25.09M -26.22M -28.19M -20.53M -14.72M
EBIT
-109.61M -72.41M -116.91M -146.51M -46.96M -50.72M -35.5M -33.77M -37.5M -26.76M -24.59M -26.8M -24.62M -25.11M -26.24M -28.21M -20.55M -14.74M
Depreciation & Amortization
8K -3.5M 9K 8K 12K 9K 16K 10K 52K 55K 55K 60K 107K 18K 21K 23K 20K 15K